Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models.

MLA

Thomas, Elizabeth, et al. “Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models.” Cells, vol. 11, no. 17, Aug. 2022. EBSCOhost, https://doi.org/10.3390/cells11172699.

APA

Thomas, E., Thankan, R. S., Purushottamachar, P., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N. P., Weber, D. J., & Njar, V. C. O. (2022). Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models. Cells, 11(17). https://doi.org/10.3390/cells11172699

Chicago

Thomas, Elizabeth, Retheesh S Thankan, Puranik Purushottamachar, Weiliang Huang, Maureen A Kane, Yuji Zhang, Nicholas P Ambulos, David J Weber, and Vincent C O Njar. 2022. “Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models.” Cells 11 (17). doi:10.3390/cells11172699.